Iterum Therapeutics faces a mixed reception for its therapy for uncomplicated urinary tract infections (UTIs) as experts ...

Takeda has secured the Japanese MHLW approval for its FRUZAQLA to treat unresectable advanced or recurrent colorectal cancer ...

The EMA CHMP has recommended granting approval for AstraZeneca’s Fasenra for eosinophilic granulomatosis with polyangiitis ...

Discover how Oxford BioMedica's new patent enhances viral vector production efficiency with a novel nucleic acid sequence that regulates therapeutic protein translation.

Discover Lyra Therapeutics' patented sinus scaffolds for chronic sinusitis treatment, enhancing localized delivery of mometasone furoate for improved patient outcomes.

Discover Premier Inc.'s groundbreaking patent for stable phytonadione compositions, designed to enhance safety and efficacy while minimizing allergic reactions.

Discover AcelRx's patented oral drug delivery device, enhancing safety and precision with innovative features for sub-lingual administration of sufentanil tablets.

Discover Nykode Therapeutics' groundbreaking anticancer vaccine patent, featuring innovative polynucleotides and neoepitopes designed to enhance cancer treatment efficacy.

Discover how Memorial Sloan Kettering's new patent for innovative compounds could revolutionize treatments for Chagas disease, malaria, and sleeping sickness.

Discover Arrowhead Pharmaceuticals' groundbreaking patent for novel linking agents that enhance oligonucleotide delivery, boosting RNAi applications with improved stability and activity.

Discover Editas Medicine's groundbreaking patent for enzymatically active Cas9 fusion molecules, enhancing gene editing precision with innovative nucleic acid applications.

Discover Nurix Therapeutics' groundbreaking patent for Cbl-b inhibitors, aimed at enhancing immune response and treating cancer through innovative compounds and methods.